New Drug Research and Development Center
Overview
The New Drug Research and Development Center is researching and developing new drugs and
new drug targets utilizing epigenetic modification mechanisms for Cancer and cardio-cerebrovascular diseases and dementia.
-
Anticancer
Brain cancer, breast cancer, lymph cancer
Development of treatment for intractable carcinoma -
Vascular Dementia
Vascular Cognitive Impairment (VCI)
Stroke / Transient ischemic Attack (TIA) -
Neurodegenerative Disease
Frontotemporal Dementia
Alzheimer’s Disease / Parkinson’s Disease
Pipeline
EDGC New Drug R&D Center conducts researches with the goal to
make possible from diagnosis to care through genomic diagnosis and new drug development for cancer and neuro diseases.
-
Cancer
Cancer is well known as a disease caused by abnormalities in the immune system from stress, poor diet and lifestyle and is one of the most feared diseases.
In order to overcome cancer, EDGC New Drug R&D Center is undergoing efforts to develop targeted anticancer drugs and new drugs that can maximize their efficacy as therapeutics of various cancers including intractable cancers.- Combination Anticancer
- EC-311
- Targeted Anticancer
- EC-321H
-
Neuro Diseases
As our society is aging, the number of patients with stress and degenerated-related cardiovascular and cerebrovascular diseases is steadily increasing.
Cardio-cerebrovascular disease is the leading cause of death in Korea besides cancer. The New Drug R&D Center is developing cures for stroke and neurodegenerative diseases through finding new drug targets and developing new chemicals.- Vascular Dementia
- EB-311
- Neurodegenerative
- EB-201H
- Frontotemporal Dementia
- EB-120